Page 1 of Clinical Trials for "Cystadenocarcinoma, Serous", 93 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
ABT-888 With Cyclophosphamide in Refractory BRCA-Positive Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple-Negative Breast Cancer, and Low-Grade Non-Hodgkin's Lymphoma
Last Updated: March 14, 2012
Condition(s): Ovarian; Primary Peritoneal; Serous Carcinoma; Triple-Negative Breast; Fallopian Tube
2
Completed
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
Last Updated: April 22, 2012
Condition(s): Uterine Cancer
3
Active, not recruiting
Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
Last Updated: September 21, 2011
Condition(s): Uterine Cancer
4
Active, not recruiting
Papillary Serous Carcinoma of the Endometrium
Last Updated: January 13, 2012
Condition(s): Endometrial Cancer
5
Active, not recruiting
Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer
Last Updated: November 15, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mixed Epithelial Carcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Serous Cystadenocarcinoma; Ovarian Undifferentiated Adenocarcinoma; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Ovarian Epithelial Cancer
6
Completed
Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy
Last Updated: March 28, 2012
Condition(s): Brenner Tumor; Fallopian Tube Cancer; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mixed Epithelial Carcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Serous Cystadenocarcinoma; Ovarian Undifferentiated Adenocarcinoma; Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Ovarian Epithelial Cancer
7
Not yet recruiting
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
Last Updated: May 3, 2011
Condition(s): Endometrial Cancer
8
Active, not recruiting
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
Last Updated: April 30, 2011
Condition(s): Endometrial Cancer
9
Active, not recruiting
Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System
Last Updated: October 21, 2011
Condition(s): Ovarian Cancer
10
Active, not recruiting
AZD6244 in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
Last Updated: October 28, 2010
Condition(s): Ovarian Cancer; Peritoneal Cavity Cancer
11
Not yet recruiting
Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer
Last Updated: April 23, 2012
Condition(s): Ovarian Cancer
12
Recruiting
Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Liver Cancer, Islet Cell Cancer, or Carcinoid Tumor
Last Updated: May 2, 2012
Condition(s): Endometrial Cancer; Gastrointestinal Carcinoid Tumor; Islet Cell Tumor; Liver Cancer; Lung Cancer; Ovarian Cancer
13
Recruiting
Beta-Blocker / Ovarian
Last Updated: March 13, 2012
Condition(s): Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer
14
Completed
Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
Last Updated: April 23, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
15
Terminated
Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity Cancer
Last Updated: January 3, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
16
Active, not recruiting
Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer
Last Updated: April 19, 2011
Condition(s): Ovarian Cancer; Primary Peritoneal Cavity Cancer
17
Not yet recruiting
Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Last Updated: March 6, 2009
Condition(s): Ovarian Cancer; Peritoneal Cavity Cancer
18
Suspended
A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Last Updated: December 15, 2010
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
19
Recruiting
Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Last Updated: July 20, 2011
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
20
Suspended
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Last Updated: February 10, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Cystadenocarcinoma%2C+Serous%22

Page 1 of Clinical Trials for "Cystadenocarcinoma, Serous", 93 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About